|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute Kidney Injury:Global Health Alert显示文摘Acute kidney injury(AKI) is increasingly prevalent in developing and developed countries and is associated with severe morbidity and mortality.Most etiologies of AKI can be prevented by interventions at the individual,community,regional and in-hospital levels.Effective measures must include community-wide efforts to increase an awareness of the devastating effects of AKI and provide guidance on preventive strategies,as well as early recognition and management.Efforts should be focused on minimizing causes of AKI,increasing awareness of the importance of serial measurements of serum creatinine in high risk patients,and documenting urine volume in acutely ill people to achieve early diagnosis;there is as yet no definitive role for alternative biomarkers.Protocols need to be developed to systematically manage prerenal conditions and specific infections.More accurate data about the true incidence and clinical impact of AKI will help to raise the importance of the disease in the community,increase awareness of AKI by governments,the public,general and family physicians and other health care professionals to help prevent the disease.Prevention is the key to avoid the heavy burden of mortality and morbidity associated with AKI. | Philip Kam Tao Li Emmanuel A Burdmann Ravindra L Mehta | 2013 | 肾脏病与透析肾移植杂志2013,22,1: | 14 |
| 2 | Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults : results of a prospective , randomized , double - blind multicenter study 显示文摘 | TOMERA K M BTomera K M BURDMANN E A | 2002 | Antimicrob Agents Chemother2002,46,9: | 1 |
| 3 | A trial of darbepoetin al- fa in type 2 diabetes and chronic kidney disease 显示文摘 | Pfeffer MA Burdmann EA Chen CY | 2009 | N Engl J Med2009,361,21: | 1 |
| 4 | International Society of Nephrology's 0by25 initiative for acute kidney injury (zero pre- ventable deaths by 2025 ) : a human rights case for nephrology 显示文摘 | Mehta RL Cerd6 J Burdmann EA | 2015 | Lancet2015,385,9987: | 1 |
| 5 | Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study 显示文摘 | Burdmann EA Reyna OG | 2002 | Antimicrob Agents Chemother2002,46,9: | 1 |
| 6 | Acute kidney iniury global health alert显示文摘 | LIP K BURDMANN E A MEHTA R L | 2013 | Kidney Int2013,83,3: | 1 |
| 7 | Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults:results of a prospective,randomized,double-blind multicenter study显示文摘 | Tomera K M Burdmann E A Pamo Reyna O G | 2002 | Antimicrob Agents Chemother2002,46,9: | 1 |
| 8 | Acute kidney injury:global health alert显示文摘 | Li PK Burdmann EA Mehta RL | | 0,,05: | 1 |
| 9 | Oxygen therapy improves renal function in patients with chronic obstructive pulmonary disease显示文摘 | Lima MR Burdmann EA Cipullo JP | 2005 | Ren Fail2005,27,4: | 1 |
| 10 | Timing of initiation and discontinuation of renal replacement therapy in AKI : unanswered key questions 显示文摘 | Gibney N Hoste E Burdmann EA | 2008 | Clinical intensive Care2008,3,3: | 1 |
| 11 | A trim of darbepoietin alfa in 2 diabetes and chronic kidney disease显示文摘 | Pfeffer MA Burdmann EA Chen CY | 2009 | N Engl J Med2009,361,21: | 1 |
| 12 | A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease显示文摘 | Pfeffer MA Burdmann EA Chen CY | 2009 | N Engl J Sed2009,361,: | 1 |
| 13 | Cyclosporine A induced arteriopathy in a rat model of chronic cyclosporine nephropathy显示文摘 | Young BA Burdmann EA Johnson RJ | 1995 | Kindeyint1995,48,: | 1 |
| 14 | Acute kidney injury:global health alert显示文摘 | Li PK Burdmann EA Mehta RL | 2013 | Kidney Int2013,83,: | 1 |
| 15 | Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy显示文摘 | Young BA Burdmann EA Johnson PJ | 1995 | Kidney Int1995,48,: | 1 |
| 16 | Acute kidney injury:Acute kidney injury-global health alert 显示文摘 | Li PK Burdmann EA Mehta RL | 2013 | Nat Rev Nephrol2013,9,3: | 1 |
| 17 | Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study显示文摘 | Burdmann EA Reyna OG | 2002 | Antimicrob Agents Chemother2002,46,: | 1 |
| 18 | A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease 显示文摘 | Pfeffer M A Burdmann E A Chert C Y et at | 2009 | N Engl J Med2009,361,21: | 1 |
| 19 | Acute kidney injury: global health alert 显示文摘 | Li PK Burdmann EA Mehta RL | 2013 | Transplantation2013,95,5: | 1 |
| 20 | Prostatic surgery associated acute kidney injury显示文摘Acute kidney injury(AKI) is associated with extended hospital stays,high risks of in-hospital and long-term mortality,and increased risk of incident and progressive chronic kidney disease.Patients with urological diseases are a high-risk group for AKI owing to the coexistence of obstructive uropathy,older age,and preexistent chronic kidney disease.Nonetheless,precise data on the incidence and outcomes of postoperative AKI in urological procedures are lacking.Benign prostatic hyperplasia and prostate cancer are common diagnoses in older men and are frequently treated with surgical procedures.Whereas severe AKI after prostate surgery in general appears to be unusual,AKI associated with transurethral resection of the prostate(TURP) syndrome and with rhabdomyolysis(RM) after radical prostatectomy have been frequently described.The purpose of this review is to discuss the current knowledge regarding the epidemiology,risk factors,outcomes,prevention,and treatment of AKI associated with prostatic surgery.The mechanisms of TURP syndrome and RM following prostatic surgeries will be emphasized. | Elerson Carlos Costalonga Ver?nica Torres Costa e Silva Renato Caires James Hung Luis Yu Emmanuel A Burdmann | 2014 | World Journal of Nephrology2014,3,4: | 1 |